Ann DeWitt is a General Partner at Engine Ventures, where they invest in seed through Series B and other early-stage venture rounds across biotechnology, life sciences, artificial intelligence, and big data. They invest in companies in the United States, with a focus on Greater Boston, the East Coast, and New England. DeWitt serves on the boards of ImmuneXcite and WEST (Women in the Enterprise of Science and Technology), and has invested in companies including Bexorg, Predicta Biosciences, Vaxess Technologies, Kano Therapeutics, and Droplet Biosciences. Before Engine Ventures, DeWitt was a General Partner and COO at The Engine; earlier roles include Senior Director positions at Sanofi and Sanofi-Genzyme BioVentures, Senior Director of Corporate Development at Permeon Biologics, Senior Associate at Flagship Ventures, and positions at 3M Company and the University of Minnesota, as well as serving with Springboard Enterprises and WEST. DeWitt attended Harvard Business School and lives in Cambridge, Massachusetts.
Ann DeWitt, General Partner @ Engine. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Ann DeWitt from Engine Ventures. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Ann
Map your path to Ann instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Ann
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.